Skip to main
ALAB
ALAB logo

ALAB Stock Forecast & Price Target

ALAB Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 41%
Buy 41%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Astera Labs Inc demonstrates a strong financial outlook, propelled by significant revenue growth of 76.5% year-over-year and an anticipated quarterly revenue of $249.0 million, well above previous estimates. The company's advancements in AI infrastructure are driving accelerated demand for its products, particularly with over 20% of revenue stemming from PCIe Gen 6 offerings, which contribute positively to average selling prices. Furthermore, Astera's industry-leading gross margins and expected increases in estimates, driven by higher AI server shipments and retimer attach rates, highlight its position as a leading growth candidate within the semiconductor sector.

Bears say

Astera Labs Inc. faces a negative outlook primarily due to its revenue growth being highly dependent on the pace of data center infrastructure spending, which is vulnerable to macroeconomic slowdowns in capital investment. The company reported non-GAAP operating expenses of $70.7 million for the quarter, coming in below estimates, indicating potential cost management challenges that could impact future profitability. Overall, these financial indicators suggest a precarious position for Astera Labs in an uncertain economic environment, leading to concerns regarding its stock performance.

ALAB has been analyzed by 17 analysts, with a consensus rating of Buy. 41% of analysts recommend a Strong Buy, 41% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Astera Labs Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Astera Labs Inc (ALAB) Forecast

Analysts have given ALAB a Buy based on their latest research and market trends.

According to 17 analysts, ALAB has a Buy consensus rating as of Nov 27, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $184.53, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $184.53, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Astera Labs Inc (ALAB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.